domingo, 11 de noviembre de 2018

Best serum biomarker combination for ovarian cancer classification. - PubMed - NCBI

Best serum biomarker combination for ovarian cancer classification. - PubMed - NCBI



 2018 Nov 6;17(Suppl 2):152. doi: 10.1186/s12938-018-0581-6.

Best serum biomarker combination for ovarian cancer classification.

Song HJ1Yang ES2,3Kim JD2,3Park CY2,3Kyung MS4Kim YS2,3.

Abstract

BACKGROUND:

Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer.

METHODS:

In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression.

RESULTS:

The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer.

CONCLUSIONS:

We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important.

KEYWORDS:

CA-125; Classification; Logistic regression; Marker selection; Ovarian cancer

PMID:
 
30396341
 
PMCID:
 
PMC6219009
 
DOI:
 
10.1186/s12938-018-0581-6

No hay comentarios:

Publicar un comentario